Estrogen Receptor-Positive Proliferating Cells in the Normal and Precancerous Breast-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estrogen Receptor-Positive Proliferating Cells in the Normal and Precancerous Breast

Published:1999-12 Issue:6 Volume:155 Page:1811-1815
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Shoker Balvinder S.,Jarvis Christine,Clarke Robert B.,Anderson Elizabeth,Hewlett Joanne,Davies Michael P.A.,Sibson D. Ross,Sloane John P.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference20 articles.

1. Reproductive and hormonal risk factors: reproductive factors and breast cancer;Kelsey;Epidemiol Rev,1993

2. Modulation of Bcl-2 and Ki67 expression in estrogen receptor positive human breast cancer by tamoxifen;Johnston;Eur J Cancer,1994

3. Clinical evidence for the involvement of estrogen in the development and progression of breast cancer;Howell;Proc R Soc Edinb,1989

4. Is tamoxifen effective in prevention of breast cancer?;Pritchard;Lancet,1998

5. Oral contraceptive (OCP) use increases proliferation and decreases estrogen receptor content of epithelial cells in the normal human breast;Williams;Int J Cancer,1991

Cited by 231 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice;Endocrinology;2024-04-29

2. Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human;2024-02-05

3. ELF5: A Molecular Clock for Breast Aging and Cancer Susceptibility;Cancers;2024-01-19

4. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO;European Journal of Surgical Oncology;2024-01

5. Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells;RSC Medicinal Chemistry;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3